FIGURE 1. MRI of the spleen. a: T1-weighted image on dynamic contrast-enhancement (axial). b: T1-weighted image on dynamic contrast-enhancement (coronal).
Case report of aseptic meningitis in a patient with Crohn's disease under infliximab therapy
β Scribed by Carolin Manthey; Ansgar W. Lohse; Andrea Pace
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 40 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Immunosuppressive therapy with anti-tnf-alpha antibodies is effective in patients with inflammatory bowel disease (ibd). however, there is an increased risk for infections associated with this therapy. ## Methods: Here, we report the case of a 58-year-old patient with crohn's disea
## Background: Tumor necrosis factor is an adipocytokine possessing a well-established lipolytic effect. in crohn's disease (cd) patients, infliximab therapy may thus result in visceral fat accumulation, which is associated with an increased risk of metabolic syndrome. ## Methods: A total of 132
To the Editor: Neurological and demyelinating events have been reported rarely in association with the use of tumor necrosis factor a (TNF-a) antagonists, since only 29 cases were reported in patients exposed to infliximab (IFX) worldwide. These demyelinating diseases included multiple sclerosis, o